{
    "Trade/Device Name(s)": [
        "Opiate Enzyme Immunoassay",
        "Homogeneous Opiate Enzyme Immunoassay"
    ],
    "Submitter Information": "Lin-Zhi International, Inc.",
    "510(k) Number": "K110298",
    "Predicate Device Reference 510(k) Number(s)": [
        "K020368"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DJG"
    ],
    "Summary Letter Date": "June 17, 2011",
    "Summary Letter Received Date": "June 20, 2011",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.3650"
    ],
    "Regulation Name(s)": [
        "Opiate Test System"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Opiates"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Hitachi 717 automated clinical system analyzers",
        "Automated clinical chemistry analyzers"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme immunoassay (EIA)",
        "Homogeneous enzyme immunoassay"
    ],
    "Methodologies": [
        "Spectrophotometric absorbance at 340 nm",
        "Competition assay using enzyme-labeled drug and antibody"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Lin-Zhi International Opiate Enzyme Immunoassay for qualitative and semi-quantitative detection of opiates in urine on automated analyzers",
    "Indications for Use Summary": "Intended for qualitative and semi-quantitative determination of opiates in human urine at a cutoff value of 300 ng/mL when calibrated against morphine, for professional use with automated clinical chemistry analyzers; provides preliminary analytical result requiring confirmatory testing",
    "fda_folder": "Toxicology"
}